Verloes Bourguignon syndrome
|
0.810 |
GeneticVariation
|
disease |
BEFREE |
Another patient with a novel homozygous splice site acceptor (c.1721-2A>G) mutation in LTBP3 was affected with dental anomalies and short stature (DASS).
|
30887145 |
2019 |
Verloes Bourguignon syndrome
|
0.810 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
This mouse model demonstrates phenotypic overlap with Verloes Bourguignon syndrome, also caused by mutation of LTBP3, which is hallmarked by craniofacial anomalies and amelogenesis imperfecta phenotypes.
|
28084688 |
2017 |
Verloes Bourguignon syndrome
|
0.810 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in the latent TGF-beta binding protein 3 (LTBP3) gene cause brachyolmia with amelogenesis imperfecta.
|
25669657 |
2015 |
Verloes Bourguignon syndrome
|
0.810 |
Biomarker
|
disease |
MGD |
Mutations in the latent TGF-beta binding protein 3 (LTBP3) gene cause brachyolmia with amelogenesis imperfecta.
|
25669657 |
2015 |
Verloes Bourguignon syndrome
|
0.810 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in the latent TGF-beta binding protein 3 (LTBP3) gene cause brachyolmia with amelogenesis imperfecta.
|
25669657 |
2015 |
Verloes Bourguignon syndrome
|
0.810 |
Biomarker
|
disease |
MGD |
E-selectin ligand-1 regulates growth plate homeostasis in mice by inhibiting the intracellular processing and secretion of mature TGF-beta.
|
20530870 |
2010 |
Verloes Bourguignon syndrome
|
0.810 |
Biomarker
|
disease |
MGD |
Bone defects in latent TGF-beta binding protein (Ltbp)-3 null mice; a role for Ltbp in TGF-beta presentation.
|
12379497 |
2002 |
Verloes Bourguignon syndrome
|
0.810 |
Biomarker
|
disease |
MGD |
Bone abnormalities in latent TGF-[beta] binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-[beta] bioavailability.
|
11790802 |
2002 |
Verloes Bourguignon syndrome
|
0.810 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Amelogenesis Imperfecta
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
This mouse model demonstrates phenotypic overlap with Verloes Bourguignon syndrome, also caused by mutation of LTBP3, which is hallmarked by craniofacial anomalies and amelogenesis imperfecta phenotypes.
|
28084688 |
2017 |
Amelogenesis Imperfecta
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
This mouse model demonstrates phenotypic overlap with Verloes Bourguignon syndrome, also caused by mutation of LTBP3, which is hallmarked by craniofacial anomalies and amelogenesis imperfecta phenotypes.
|
28084688 |
2017 |
Amelogenesis Imperfecta
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the latent TGF-beta binding protein 3 (LTBP3) gene cause brachyolmia with amelogenesis imperfecta.
|
25669657 |
2015 |
Amelogenesis Imperfecta
|
0.620 |
Biomarker
|
disease |
CTD_human |
Mutations in the latent TGF-beta binding protein 3 (LTBP3) gene cause brachyolmia with amelogenesis imperfecta.
|
25669657 |
2015 |
Amelogenesis Imperfecta
|
0.620 |
Biomarker
|
disease |
HPO |
|
|
|
GELEOPHYSIC DYSPLASIA 3
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in LTBP3 cause acromicric dysplasia and geleophysic dysplasia.
|
27068007 |
2016 |
GELEOPHYSIC DYSPLASIA 3
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in LTBP3 cause acromicric dysplasia and geleophysic dysplasia.
|
27068007 |
2016 |
GELEOPHYSIC DYSPLASIA 3
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Hypodontia
|
0.410 |
Biomarker
|
disease |
CTD_human |
New recessive truncating mutation in LTBP3 in a family with oligodontia, short stature, and mitral valve prolapse.
|
25899461 |
2015 |
Hypodontia
|
0.410 |
GeneticVariation
|
disease |
BEFREE |
Oligodontia is caused by mutation in LTBP3, the gene encoding latent TGF-beta binding protein 3.
|
19344874 |
2009 |
Hypodontia
|
0.410 |
Biomarker
|
disease |
CTD_human |
Oligodontia is caused by mutation in LTBP3, the gene encoding latent TGF-beta binding protein 3.
|
19344874 |
2009 |
Hypodontia
|
0.410 |
Biomarker
|
disease |
HPO |
|
|
|
Osteoarthritis of hip
|
0.400 |
GeneticVariation
|
disease |
GWASCAT |
Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank data.
|
30664745 |
2019 |
Osteoarthritis of hip
|
0.400 |
Biomarker
|
disease |
CTD_human |
Meta-analysis of Icelandic and UK data sets identifies missense variants in SMO, IL11, COL11A1 and 13 more new loci associated with osteoarthritis.
|
30374069 |
2018 |
Osteoarthritis of hip
|
0.400 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of Icelandic and UK data sets identifies missense variants in SMO, IL11, COL11A1 and 13 more new loci associated with osteoarthritis.
|
30374069 |
2018 |
Mitral Valve Prolapse Syndrome
|
0.400 |
Biomarker
|
disease |
CTD_human |
New recessive truncating mutation in LTBP3 in a family with oligodontia, short stature, and mitral valve prolapse.
|
25899461 |
2015 |